Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (341-350 of 388) with videos related to

Pageof 39
Sort By:
BMJ Global Health|May 15, 2024
Long-term healthcare utilisation, costs and quality of life after invasive group B <i>Streptococcus</i> disease: a cohort study in five low-income and middle-income countriesFarah Seedat, Simon Procter, Ziyaad Dangor, et al.
Vaccine|September 30, 2023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, et al.
Vaccine|April 21, 2026
Vaccine value profile for severe fever with thrombocytopenia syndrome (SFTS)Laura Skrip, Arata Hidano, Yong Poovorawan, et al.
Plos Medicine|July 18, 2024
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling studyGabrielle Bonnet, John Bimba, Chancy Chavula, et al.
Human Vaccines & Immunotherapeutics|August 12, 2015
Modeling the impact of rubella vaccination in VietnamEmilia Vynnycky, Lay Myint Yoshida, Dang Thi Thanh Huyen, et al.
Journal of Medical Internet Research|May 12, 2025
Population-Wide Depression Incidence Forecasting Comparing Autoregressive Integrated Moving Average and Vector Autoregressive Integrated Moving Average to Temporal Fusion Transformers: Longitudinal Observational StudyDeliang Yang, Yiyi Tang, Vivien Kin Yi Chan, et al.
BMC Medicine|June 20, 2024
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort studyLiang-Yu Lin, Alasdair D Henderson, Oliver Carlile, et al.
Pharmacoeconomics|October 19, 2015
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityBernhard Ultsch, Oliver Damm, Philippe Beutels, et al.
Lancet (London, England)|November 10, 2015
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical modelsMelissa A Penny, Robert Verity, Caitlin A Bever, et al.
Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
Pageof 39

Showing results (341-350 of 388) with videos related to

Sort By:
Pageof 39
BMJ Global Health|May 15, 2024
Long-term healthcare utilisation, costs and quality of life after invasive group B <i>Streptococcus</i> disease: a cohort study in five low-income and middle-income countriesFarah Seedat, Simon Procter, Ziyaad Dangor, et al.
Vaccine|September 30, 2023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, et al.
Vaccine|April 21, 2026
Vaccine value profile for severe fever with thrombocytopenia syndrome (SFTS)Laura Skrip, Arata Hidano, Yong Poovorawan, et al.
Plos Medicine|July 18, 2024
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling studyGabrielle Bonnet, John Bimba, Chancy Chavula, et al.
Human Vaccines & Immunotherapeutics|August 12, 2015
Modeling the impact of rubella vaccination in VietnamEmilia Vynnycky, Lay Myint Yoshida, Dang Thi Thanh Huyen, et al.
Journal of Medical Internet Research|May 12, 2025
Population-Wide Depression Incidence Forecasting Comparing Autoregressive Integrated Moving Average and Vector Autoregressive Integrated Moving Average to Temporal Fusion Transformers: Longitudinal Observational StudyDeliang Yang, Yiyi Tang, Vivien Kin Yi Chan, et al.
BMC Medicine|June 20, 2024
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort studyLiang-Yu Lin, Alasdair D Henderson, Oliver Carlile, et al.
Pharmacoeconomics|October 19, 2015
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityBernhard Ultsch, Oliver Damm, Philippe Beutels, et al.
Lancet (London, England)|November 10, 2015
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical modelsMelissa A Penny, Robert Verity, Caitlin A Bever, et al.
Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
Pageof 39